169 related articles for article (PubMed ID: 26775918)
21. Hepatocellular carcinoma: From diagnosis to treatment.
Grandhi MS; Kim AK; Ronnekleiv-Kelly SM; Kamel IR; Ghasebeh MA; Pawlik TM
Surg Oncol; 2016 Jun; 25(2):74-85. PubMed ID: 27312032
[TBL] [Abstract][Full Text] [Related]
22. Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.
Gandhi M; Choo SP; Thng CH; Tan SB; Low AS; Cheow PC; Goh AS; Tay KH; Lo RH; Goh BK; Wong JS; Ng DC; Soo KC; Liew WM; Chow PK;
BMC Cancer; 2016 Nov; 16(1):856. PubMed ID: 27821083
[TBL] [Abstract][Full Text] [Related]
23. New developments in the treatment of hepatic tumors.
Di Carlo I; Toro A
Future Oncol; 2012 Apr; 8(4):391-4. PubMed ID: 22515441
[TBL] [Abstract][Full Text] [Related]
24. Advanced Hepatocellular Cancer: the Current State of Future Research.
Connell LC; Harding JJ; Abou-Alfa GK
Curr Treat Options Oncol; 2016 Aug; 17(8):43. PubMed ID: 27344158
[TBL] [Abstract][Full Text] [Related]
25. Multidisciplinary Team Management of Hepatocellular Carcinoma Is Standard of Care.
Lhewa D; Green EW; Naugler WE
Clin Liver Dis; 2020 Nov; 24(4):771-787. PubMed ID: 33012458
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal?
Cabibbo G; Antonucci M; Sacco R; Sciarrino E
Expert Rev Anticancer Ther; 2015 Feb; 15(2):147-50. PubMed ID: 25558787
[TBL] [Abstract][Full Text] [Related]
27. Mexican consensus on the diagnosis and management of hepatocellular carcinoma.
González Huezo MS; Sánchez Ávila JF; ; ; ; ; ;
Rev Gastroenterol Mex; 2014; 79(4):250-62. PubMed ID: 25487133
[TBL] [Abstract][Full Text] [Related]
28. [Hepatocellular carcinoma: a multidisciplinary approach].
Tempia-Caliera AA; Ksontini R; Moradpour D; Denys A; Halkic N
Rev Med Suisse; 2005 Jun; 1(24):1621-4, 1627-9. PubMed ID: 16028708
[TBL] [Abstract][Full Text] [Related]
29. Basic science focus of third international symposium on liver cancer and hepatitis.
Skolnick AA
JAMA; 1996 Nov; 276(18):1457-8. PubMed ID: 8903244
[No Abstract] [Full Text] [Related]
30. [Hepatocellular carcinoma].
Semela D; Heim M
Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
[TBL] [Abstract][Full Text] [Related]
31. [Hepatocellular carcinoma - from immunobiology to immunotherapy].
Flecken T; Schmidt N; Spangenberg HC; Thimme R
Z Gastroenterol; 2012 Jan; 50(1):47-56. PubMed ID: 22222798
[TBL] [Abstract][Full Text] [Related]
32. Management of hepatocellular carcinoma.
Lau WY
J R Coll Surg Edinb; 2002 Feb; 47(1):389-99. PubMed ID: 11874260
[TBL] [Abstract][Full Text] [Related]
33. Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.
Liu F; Meng Z; Shao G; Wang J; Wang Z; Yang J; Yip CS; He D
Mol Biol Rep; 2017 Feb; 44(1):149-158. PubMed ID: 27981445
[TBL] [Abstract][Full Text] [Related]
34. Interventional oncology for hepatocellular carcinoma.
Delicque J; Boulin M; Guiu B; Pelage JP; Escal L; Schembri V; Assenat E; Fohlen A
Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):530-537. PubMed ID: 27055387
[TBL] [Abstract][Full Text] [Related]
35. Potentiality of immunotherapy against hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and treatment of hepatocellular carcinoma in Thailand.
Chonprasertsuk S; Vilaichone RK
Jpn J Clin Oncol; 2017 Apr; 47(4):294-297. PubMed ID: 28042136
[TBL] [Abstract][Full Text] [Related]
37. Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.
Kudo M; Lencioni R; Marrero JA; Venook AP; Bronowicki JP; Chen XP; Dagher L; Furuse J; Geschwind JF; Ladrón de Guevara L; Papandreou C; Sanyal AJ; Takayama T; Yoon SK; Nakajima K; Lehr R; Heldner S; Ye SL
Liver Int; 2016 Aug; 36(8):1196-205. PubMed ID: 26901163
[TBL] [Abstract][Full Text] [Related]
38. International Liver Cancer Association Annual Conference.
Lokody I
Lancet Oncol; 2015 Oct; 16(13):1289. PubMed ID: 26365414
[No Abstract] [Full Text] [Related]
39. [Advances in basic and clinical research on hepatocellular carcinoma in 2016].
Dong ZZ; Zhu XD; Li Z; Mao YG; Chai YL; Yao DF; Sun HC; Zhu JY; Ma KS
Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):85-93. PubMed ID: 28297792
[TBL] [Abstract][Full Text] [Related]
40. Systemic therapies in hepatocellular carcinoma: present and future.
Bertino G; Di Carlo I; Ardiri A; Calvagno GS; Demma S; Malaguarnera G; Bertino N; Malaguarnera M; Toro A; Malaguarnera M
Future Oncol; 2013 Oct; 9(10):1533-48. PubMed ID: 24106903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
